Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 590,448 | 581,225 | 456,260 | 380,880 | 362,041 |
| Gross Profit | 590,448 | 581,225 | 456,260 | 380,880 | 362,041 |
| Operating Expenses | 40,069 | 34,914 | 29,755 | 25,469 | 18,338 |
| Operating Income | 550,379 | 546,311 | 426,505 | 355,411 | 343,703 |
| Interest Expense | 27,059 | 39,211 | 24,871 | 29,036 | 36,102 |
| Other Income | 6,818 | -5,828 | 242 | 758 | -173 |
| Pre-tax Income | 530,138 | 501,272 | 401,876 | 327,133 | 307,428 |
| Income Tax | 197,343 | 179,028 | 137,346 | 115,464 | 108,039 |
| Net Income Continuous | 332,795 | 322,244 | 264,530 | 211,669 | 199,389 |
| Net Income | $332,795 | $322,244 | $264,530 | $211,669 | $199,389 |
| EPS Basic Total Ops | 2.04 | 2.04 | 1.89 | 1.52 | 1.43 |
| EPS Basic Continuous Ops | 2.04 | 2.04 | 1.89 | 1.52 | 1.43 |
| EPS Diluted Total Ops | 2.03 | 1.86 | 1.66 | 1.45 | 1.15 |
| EPS Diluted Continuous Ops | 2.03 | 1.86 | 1.66 | 1.45 | 1.12 |
| EPS Diluted Before Non-Recurring Items | 2.03 | 1.89 | N/A | N/A | N/A |
| EBITDA(a) | $563,382 | $564,873 | $439,421 | $370,064 | $355,027 |